What is the recommended treatment for Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Lyme Disease

The recommended first-line treatment for early Lyme disease is doxycycline (100 mg twice daily), amoxicillin (500 mg three times daily), or cefuroxime axetil (500 mg twice daily) for 14 days (range 10-21 days), with doxycycline being preferred when co-infections like Human Granulocytic Anaplasmosis are suspected. 1

Treatment by Disease Stage

Early Localized Lyme Disease (Erythema Migrans)

  • Oral antibiotics for 14 days (range 10-21 days):
    • Doxycycline: 100 mg twice daily (adults)
    • Amoxicillin: 500 mg three times daily (adults)
    • Cefuroxime axetil: 500 mg twice daily (adults) 1

Pediatric Dosing

  • For children:
    • Amoxicillin: 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose)
    • Cefuroxime axetil: 30 mg/kg/day in 2 divided doses (maximum 500 mg per dose)
    • Doxycycline: 4 mg/kg/day in 2 divided doses (maximum 100 mg per dose) for children ≥8 years 1

Early Disseminated or Late Lyme Disease

  • For neurological involvement (meningitis or radiculopathy):
    • IV ceftriaxone: 2g daily for 14 days (range 10-28 days) 1
  • For isolated facial nerve palsy without CSF abnormalities:
    • Same oral regimen as for erythema migrans for 14 days 1
  • For facial nerve palsy with CSF abnormalities:
    • Treatment as for meningitis 1
  • For Lyme arthritis that has failed to improve or worsened:
    • IV ceftriaxone: 2g daily for 2-4 weeks 1

Important Clinical Considerations

Antibiotic Selection

  • Doxycycline has the advantage of covering potential co-infections like Human Granulocytic Anaplasmosis 1
  • Macrolide antibiotics are not recommended as first-line therapy due to lower efficacy 1
  • First-generation cephalosporins should be avoided 1

Treatment Duration

  • Longer duration therapy beyond recommended guidelines has not been shown to be more effective 1, 2
  • A study of 607 patients in a Lyme-endemic area showed similar long-term outcomes for patients treated with 10 days versus longer courses of antibiotics, with treatment failure being extremely rare (1%) 2

Post-Treatment Considerations

  • Some patients may experience Post-Lyme Disease Syndrome with persistent symptoms after appropriate antibiotic treatment 1
  • These persistent symptoms are not due to ongoing infection and do not respond to additional antibiotics 1
  • The Infectious Diseases Society of America recommends against additional antibiotic therapy for patients with persistent symptoms who lack objective evidence of reinfection or treatment failure 1

Common Pitfalls to Avoid

  • Extending antibiotic treatment beyond recommended durations without evidence of benefit 1
  • Using first-generation cephalosporins which are ineffective 1
  • Relying solely on serologic testing for diagnosis without clinical correlation 1
  • Attributing non-specific symptoms to Lyme disease without objective evidence 1
  • Treating "chronic Lyme disease" with prolonged antibiotics when symptoms may be due to non-infectious processes 3

Prophylaxis After Tick Bite

  • A single dose of doxycycline is recommended for high-risk patients with:
    • Identified Ixodes spp. tick
    • Tick attached for ≥36 hours
    • Local infection rate of ticks with B. burgdorferi ≥20% 1

The evidence consistently supports short-course antibiotic therapy for early Lyme disease, with treatment selection based on disease stage and patient factors. Longer treatment durations have not demonstrated improved outcomes in controlled studies 1, 2.

References

Guideline

Lyme Disease Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.